Device Usability, Label Comprehension, Natural Conception, Safety Issues
Conditions
Brief summary
The study is a prospective, 1-arm, open label, nonrandomized, single center study designed to evaluate label comprehension, device usability and safety of the FERTI·LILY Conception Cup. The primary safety endpoint will be an assessment of reported adverse events. Subjects will be screened -10 (±3) days prior to the baseline visit. At baseline, 15-20 subjects meeting the inclusion/exclusion criteria will be provided with a FERTI·LILY Conception Cup device and instructions for using the device. Subjects will participate in a label comprehension protocol that includes the physician confirmation that they have adequate comprehension to enroll. If not, a screen failure form is completed. Subjects will agree to try and use the device within 2 weeks of disposition therefore at baseline a two-week visit is scheduled. In the event they do not use the device within the two-week period the follow up visit can be rescheduled based on the visit window of +14 days. If it is not used within 4 weeks, the PI will have the subject return to the site to authorize another two-week period that will be captured as unscheduled follow up visit. The subject should complete the Device Experience Survey after each device use. The Device Experience Survey will be returned at this time, and adverse events will be assessed.
Interventions
DEVICEFERTI LILY Conception Cup
The FERTI-LILY Conception Cup is indicated for over-the-counter (OTC) home use by couples trying to conceive. The FERTI·LILY device OTC contains a cervical cap attached to a stem. The FERTI-LILY Conception Cup is intended to push semen towards the cervix as an aid in conception. It is designed to be inserted vaginally after intercourse and left in place for 20-60 minutes. The device is recommended to be used during the ovulatory phase of the menstrual cycle. It is not to be left in place for longer than six hours. The device may be re-used up to 18 times or over 6 cycles.
Sponsors
Rosesta Medical BV
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Subject is a female volunteer, age ≥ 18 years. * Subject is willing and able to provide written informed consent for study participation. * Subject agrees to use the FCC device as directed. * Subject agrees to complete all study-related assessments. * Subject agrees to try to use the cup within two weeks of disposition. * PI confirms that the subject had the adequate label comprehension to enroll in the study.
Exclusion criteria
* Subject has a medical condition or other factor that, in the opinion of the investigator, would contraindicate participation in the study. * Subject has active bacterial vaginosis infection or vaginismus. * Subject has an abnormal clinically significant Pap Smear diagnosis. * Subject has a history of endometriosis. * Subject has any contraindications with the Instructions for Use. * Subject has an allergy to silicone. * Subject is pregnant or lactating.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Safety of Device | 6 weeks | Occurrence of device-related adverse events. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Label Comprehension Assessment Protocol | 6 weeks | PI using questions and answers to assess comprehension and confirms subject can specify location and use of cup in vaginal model. |
| Device Usability | 6 weeks | After use reported by subject: ease of use, user compliance, overall satisfaction, comfort, size of device. |
Countries
United States
Outcome results
None listed